Bloomberg News

Brainsway’s Deep TMS Approved to Treat Depression, Schizophrenia

October 02, 2011

Oct. 2 (Bloomberg) -- Brainsway Ltd. said Israel’s Health Minisry approved the company’s Deep TMS device to treat major depression, bipolar depression and schizophrenia, according to a statement filed today with the Tel Aviv Stock Exchange.

To contact the reporter on this story: Susan Lerner in Jerusalem at slerner2@bloomberg.net

To contact the editor responsible for this story: Jonathan Ferziger at jferziger@bloomberg.net


Coke's Big Fat Problem
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus